Cellosaurus logo
expasy logo

Cellosaurus Mel1617 (CVCL_DG51)

[Text version]
Cell line name Mel1617
Synonyms MEL1617; Mel-1617
Accession CVCL_DG51
Resource Identification Initiative To cite this cell line use: Mel1617 (RRID:CVCL_DG51)
Comments Part of: Wistar Institute melanoma cell line collection.
Population: Caucasian.
Omics: Variations; Array-based CGH.
Sequence variations
Disease Cutaneous melanoma (NCIt: C3510)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Children:
CVCL_DG52 (Mel1617-BR)CVCL_DG53 (Mel1617-MR)
Originate from same individual CVCL_7928 ! WM164
Sex of cell Male
Age at sampling 22Y
Category Cancer cell line
Publications

PubMed=21156289; DOI=10.1016/j.ccr.2010.11.023; PMCID=PMC3026446
Jessie Villanueva, Adina Vultur, John T. Lee, Rajasekharan Somasundaram, Mizuho Fukunaga-Kalabis, Angela K. Cipolla, Bradley Wubbenhorst, Xiao-Wei Xu, Phyllis A. Gimotty, Damien Kee, Ademi Elena Santiago-Walker ...Show all 21 authors... , Richard Letrero, Kurt D'Andrea, Anitha Pushparajan, James E. Hayden, Kimberly Brown Dahlman, Sylvie G. Laquerre, Grant A. McArthur, Jeffrey A. Sosman, Katherine L. Nathanson, Meenhard Herlyn; Show fewer authors
Acquired resistance to BRAF inhibitors mediated by a RAF kinase switch in melanoma can be overcome by cotargeting MEK and IGF-1R/PI3K.
Cancer Cell 18:683-695(2010)

PubMed=23285177; DOI=10.1371/journal.pone.0052760; PMCID=PMC3532357
Adam B. Schayowitz, Greg P. Bertenshaw, Emiko Jeffries, Timothy Schatz, James Cotton, Jessie Villanueva, Meenhard Herlyn, Clemens Krepler, Adina Vultur, Wei Xu, Gordon H. Yu ...Show all 13 authors... , Lynn Mara Schuchter, Douglas P. Clark; Show fewer authors
Functional profiling of live melanoma samples using a novel automated platform.
PLoS ONE 7:e52760.1-e52760.8(2012)

PubMed=24055054; DOI=10.1016/j.celrep.2013.08.023; PMCID=PMC3956616
Jessie Villanueva, Jeffrey R. Infante, Clemens Krepler, Patricia Reyes-Uribe, Minu Samanta, Hsin-Yi Chen, Bin Li, Rolf K. Swoboda, Melissa Wilson, Adina Vultur, Mizuho Fukunaga-Kalabis ...Show all 28 authors... , Bradley Wubbenhorst, Thomas Y. Chen, Qin Liu, Katrin Sproesser, Douglas J. DeMarini, Tona Morgan Gilmer, Anne-Marie Martin, Ronen Marmorstein, David C. Schultz, David W. Speicher, Giorgos Constantine Karakousis, Wei Xu, Ravi K. Amaravadi, Xiao-Wei Xu, Lynn Mara Schuchter, Meenhard Herlyn, Katherine L. Nathanson; Show fewer authors
Concurrent MEK2 mutation and BRAF amplification confer resistance to BRAF and MEK inhibitors in melanoma.
Cell Rep. 4:1090-1099(2013)

Cross-references
Cell line databases/resources cancercelllines; CVCL_DG51
Encyclopedic resources Wikidata; Q54905149
Gene expression databases GEO; GSM1199180
Polymorphism and mutation databases Progenetix; CVCL_DG51
Entry history
Entry creation13-Jul-2016
Last entry update10-Apr-2025
Version number13